Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

Correct... the trial ending in March 2022 is an 80 patient study with a PREVENTATIVE inhaler. Trial: NCT04536350

The US trial of 288 patients estimated to complete Nov 31, 2020 is the TREATMENT inhaler. Trial: NCT04360096

The US trial of 288 patients is the horse we're all betting on. According to Dr. Javitt: “We expect that half the people we enroll in our inhaled study are going to be people who are outpatients.”